A fresh view of some old and new diseases recognized by means of modern genetics and biochemistry.
A.N AREA of significant medical progress over the past decade has been the recognition and the biochemical characterization of an ever-increasing number of human hereditary diseases (1) 
Gout
Ammother enzyme deletion, which is presunied to have occurred Ill a remote ancestor of both mait aimd the higher apes, has left time whole human species heir to the gout. 1mm all other mammals, the enzyme uncase is present and degrades uric acid to its nmueim more soluble end product, ahlantoimi, for excretion. In addition, the human kidney excretes uric acid inefficiently.
As a result, time mean colicentration of mirate in human serum is quite iear time tlmeoretical liniit of solul)ihity of urate (18) .
A portion of the hyperuriceniic iil(livi(luals (leposit time sparingly soluble urate crystals in and about time joints which can give rise to erosion of joints and episodes of iimflammatory reaction clmaracteristics of the acute attack of gouty arthritis (19) . 
Glycogen Storage Disease

Brain Function Abnormalities
In recent years, we have become aware of an increasing number of specific defects of metabolism that are associated with abnormalities of brain function.
One of tlmese is known as branched-chain ketonuria or Maple Syrup Urine i)isease.
This was first described in 1954 in a family in whom 4 of the 6 children had died within the first few weeks of life from severe brain damage (2S). The mother brought to the attention of the doctors the fact that the urilme of the affecte(l children had a characteristic odor similar to that of maple syrup.
On the basis of this ol)servation, the urine was examined iii greater detail ammdan abnormal concentration of organic acids was detected which were eventually found to be the keto acids derived from time branched-chain amino acids leuciiie, valine, amid isoleucine, whelm accumulate as a result of a deficiency of time decarhoxylase that normiiahly degrades theni (1). The severe brain damage in such instances can be prevented by treatment with a syntimetic diet low iii branched-chain amino acids. This (hisease was (liagimosed in a baby S thays old; the special diet was begun immediately and has been colitillued ever since (26) . The child is now 5 years of age, has growil well, and has a iiornmal intelligence.
Other patients with this disorder lmave 1)een similarly treated
Ammotlmer imiherited biocimemical disorder which gives rise to neurologic symptoms was first described nearly three years ago (27 
